Epinephrine is the go-to first line treatment for anaphylactic shock
It’s highly effective at rapidly reversing symptoms and has no contraindications.
However, the requirement to deliver ephinephrine via intramuscular (IM) injection as soon as possible by anone nearby creates a variety of significant treatment challenges.
We have developed an epinephrine nasal spray that could transform treatment for anaphylactic shock.
The product has been validated in the clinic to match the pharmacokinetics of IM epinephrine.